CompletedPhase 2NCT01025505
Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Principal Investigator
- Michele BaccaraniPoliclinico Sant'Orsola
- Intervention
- Nilotinib(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2020
Study locations (30)
- Azienda Ospedaliera - Nuovo Ospedale "Torrette", Ancona, Italy
- Dipartimento Area Medica P.O., Ascoli Piceno, Italy
- UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari, Bari, Italy
- Ospedali Riuniti, Bergamo, Italy
- Ist.Ematologia e Oncologia Medica L.e A. Seragnoli, Bologna, Italy
- Sezione di Ematologia e Trapianti Spedali Civili, Brescia, Italy
- Osp. Reg. A. Di Summa, Brindisi, Italy
- Servizio di Ematologia - CTMO - ASL 8 P.O. Binaghi, Cagliari, Italy
- Ospedale Ferrarotto, Catania, Italy
- Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna, Ferrara, Italy
- Clinica Ematologica - Università degli Studi, Genova, Italy
- Ospedale Niguarda "Ca' Granda", Milan, Italy
- Sez. di medicina Interna Oncologia ed Ematologia, Modena, Italy
- Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Naples, Italy
- Ospedale di Rilievo Nazionale "A. Cardarelli", Naples, Italy
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01025505 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University